移动重症监护康复计划用于急性呼吸衰竭幸存者:一项随机临床试验
这项随机临床试验纳入4家印第安纳州医院ICU的466例急性呼吸衰竭幸存者(平均年龄56.1岁,53.6%女性),比较12个月护士主导、多学科团队支持的m-CCRP干预与电话对照对生活质量的影响。主要终点SF-36 PCS和MCS的变化组间差异均未达统计学显著(PCS估计差异1.61,95%CI -1.06至4.29;MCS估计差异-2.50,95%CI -5.29至0.30)。m-CCRP组住院率高于对照组(50.2% vs 40.8%,P=0.04),12个月死亡率无统计学显著降低(10.3% vs 16.3%,P=0.05)。作者认为需进一步研究识别可从个体化ICU后干预中获益的特定患者群体。
要点
- 在466例急性呼吸衰竭幸存者中,12个月护士主导多学科干预未显著改善SF-36 PCS(估计差异1.61,95%CI -1.06至4.29)和MCS(估计差异-2.50,95%CI -5.29至0.30)。
- m-CCRP组住院率高于对照组(117例[50.2%] vs 95例[40.8%],P=0.04)。
- 12个月死亡率m-CCRP组24例(10.3%)vs 对照组38例(16.3%),差异未达统计学显著(P=0.05)。
- 干预为12个月护士护理协调员主导、由2名重症医学科医师、1名老年科医师、1名ICU护士和1名神经心理学家支持的多学科协作护理。
- 作者认为需进一步研究识别可从个体化ICU后干预中获益的特定患者群体。
适用人群与场景
- 急性呼吸衰竭幸存者,收治于印第安纳州4家医院(1家社区医院、1家县医院、2家学术医院)的ICU服务,隶属印第安纳大学医学院。
处置流程与药物剂量
- m-CCRP干预:为期12个月的护士主导协作护理干预,由跨学科临床医生团队(2名重症医学科医师、1名老年科医师、1名ICU护士、1名神经心理学家)支持,包括纵向症状监测和护士实施的护理方案,针对认知、躯体功能、个人护理、活动能力、睡眠障碍、疼痛、抑郁、焦虑、激越或攻击、妄想或幻觉、压力与身体健康、法律与经济需求以及用药依从性。
- 对照组:电话为基础的对照。
研究设计与关键结果
- 研究类型:随机临床试验,采用隐蔽结局评估;2017年3月1日至2022年4月30日进行,随访12个月;4家印第安纳州医院(1家社区、1家县、2家学术)。
- 意向性治疗分析纳入466例急性呼吸衰竭幸存者(平均[SD]年龄56.1[14.4]岁;250例[53.6%]女性;每组233例)。
- 主要终点:12个月m-CCRP干预相比对照组未显著改善生活质量(SF-36 PCS基线变化估计差异1.61[95%CI -1.06至4.29];SF-36 MCS估计差异-2.50[95%CI -5.29至0.30])。
- 次要终点:m-CCRP组住院率高于对照组(117例[50.2%] vs 95例[40.8%];P=0.04)。
- 12个月死亡率m-CCRP组24例(10.3%)vs 对照组38例(16.3%),差异未达统计学显著(P=0.05)。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,护士主导的12个月综合跨学科护理干预未显著改善ICU住院后急性呼吸衰竭幸存者的生活质量;这些结果提示需进一步研究识别可从个体化ICU后干预中获益的特定患者群体。
指南或共识出处
- 临床试验注册:ClinicalTrials.gov标识符NCT03053245。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Over 50% of Acute Respiratory Failure (ARF) survivors experience cognitive, physical, and psychological impairments that negatively impact their quality of life (QOL).
OBJECTIVE: To evaluate the efficacy of a post-intensive care unit (ICU) program, the Mobile Critical Care Recovery Program (m-CCRP) consisting of a nurse care coordinator supported by an interdisciplinary team, in improving the QOL of ARF survivors.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial with concealed outcome assessments among ARF survivors was conducted from March 1, 2017, to April 30, 2022, with a 12-month follow-up. Patients were admitted to the ICU services of 4 Indiana hospitals (1 community, 1 county, 2 academic), affiliated with the Indiana University School of Medicine.
INTERVENTION: A 12-month nurse-led collaborative care intervention (m-CCRP) supported by an interdisciplinary group of clinicians (2 intensivists, 1 geriatrician, 1 ICU nurse, and 1 neuropsychologist) was compared with a telephone-based control. The intervention comprised longitudinal symptom monitoring coupled with nurse-delivered care protocols targeting cognition, physical function, personal care, mobility, sleep disturbances, pain, depression, anxiety, agitation or aggression, delusions or hallucinations, stress and physical health, legal and financial needs, and medication adherence.
MAIN OUTCOMES AND MEASURES: The primary outcome was QOL as measured by the 36-item Medical Outcomes Study Short Form Health Survey (SF-36) physical component summary (PCS) and mental component summary (MCS), with scores on each component ranging from 0-100, and higher scores indicating better health status.
RESULTS: In an intention-to-treat analysis among 466 ARF survivors (mean [SD] age, 56.1 [14.4] years; 250 [53.6%] female; 233 assigned to each group), the m-CCRP intervention for 12 months did not significantly improve the QOL compared with the control group (estimated difference in change from baseline between m-CCRP and control group: 1.61 [95% CI, -1.06 to 4.29] for SF-36 PCS; -2.50 [95% CI, -5.29 to 0.30] for SF-36 MCS. Compared with the control group, the rates of hospitalization were higher in the m-CCRP group (117 [50.2%] vs 95 [40.8%]; P = .04), whereas the 12-month mortality rates were not statistically significantly lower (24 [10.3%] vs 38 [16.3%]; P = .05).
CONCLUSIONS AND RELEVANCE: Findings from this randomized clinical trial indicated that a nurse-led 12-month comprehensive interdisciplinary care intervention did not significantly improve the QOL of ARF survivors after ICU hospitalization. These results suggest that further research is needed to identify specific patient groups who could benefit from tailored post-ICU interventions.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03053245.
参考来源
- Khan BA, Perkins AJ, Khan SH, et al. Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 38289602. doi:10.1001/jamanetworkopen.2023.53158
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。